IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental 'Triple-Target' drug tested for stubborn autoimmune illnesses
Disease control Recruiting nowThis early study is testing the safety of a new drug called CC312 in adults with severe autoimmune diseases that have not improved with standard treatments. The drug works by engaging the body's own immune T cells to attack harmful B cells, using a mechanism similar to some advan…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First-of-its-Kind cell therapy trial targets devastating muscle disease
Disease control Recruiting nowThis is a very early study to see if a new type of cell therapy called GC012F is safe and might help adults with a severe form of inflammatory muscle disease that hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to pote…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Engineered immune cells target devastating autoimmune diseases in groundbreaking trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for people with severe autoimmune diseases that haven't improved with standard treatments. Doctors will give patients specially engineered immune cells (CAR-NK cells) to try to reset their overactive immune systems. The main go…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC
-
Blood test could end arthritis medication guesswork
Diagnosis Recruiting nowThis study is testing a new blood test designed to predict which arthritis medications will work best for individual patients before they start treatment. Researchers will analyze blood samples from 120 people with various autoimmune rheumatic diseases to see if the test can accu…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC